机构:[1]Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China浙江大学医学院附属第一医院[2]Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China[3]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[4]Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院[5]Department of Thoracic Surgery, Henan Cancer Hospital, Zhengzhou, China河南省肿瘤医院[6]Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, China[7]Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, China[8]Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China[9]Department of Thoracic Surgery, Chinese People’s Liberation Army General Hospital, Beijing, China[10]Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China[11]Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China[12]Medical Affairs, Linkdoc Technology Co, Ltd, Beijing, China
Studies of surgical approach selection for operable small cell lung cancer (SCLC) are lacking. We retro- spectively enrolled 169 patients with pathologically confirmed T1 stage SCLC who underwent video-assisted thoracic surgery (VATS) or open lobectomy. Open surgery does not significantly increase the perioperative risk, but lymph node dissection can be done more thoroughly. The recommendation of VATS as a routine approach for SCLC surgery may still require further study, and until then, open surgery should still be considered.
Background: Video-assisted thoracic surgery ( VATS) has been widely used in the surgical treatment of thoracic diseases, and it suggested surgical and oncological advantages compared with open surgery. However, reports on the application of VATS in surgery of small cell lung cancer (SCLC) are scarce. This study aimed to explore the advan- tages and disadvantages of different surgical approaches in the treatment of pathological stage T1(pT1) SCLC in terms of safety, clinical outcomes, and lymph node dissection. Patients and Methods: Patients who underwent lobectomy for pT1 SCLC between January 2014 and September 2017 were identified from the National Collaborative Lung Cancer Database (LinkDoc Database). The patients were stratified based on the surgery approach (VATS or open lobectomy). Perioperative outcomes and long-term survival were analyzed using SPSS software. Results: A total of 169 patients with pT1 SCLC met the cr iter ia and were enrolled for this study, including 110 cases of VATS lobectomies and 59 cases of open lobectomies. VATS lobectomy was associated with less blood loss than open surgery (168.1 ±237.4 vs. 340.0 ±509.8 mL, P = .002). Open lobectomy harvested more N2 LNs (11.8 ±8.2 vs. 8.4 ±5.8, P = .048) and identified more metastasis positive LNs (3.1 ±6.0 vs. 1.4 ±3.0, P = .050). Open lobectomy associated with longer overall survival (OS) but has no statistical difference (23.4 ±13.2 vs. 20.2 ±10.9, P = .070). Conclusion: Open lobectomy had better lymph node dissection results, and comparable postoperative complications, postoperative hospital stay, and OS to VATS lobectomy. Further studies may still be needed to confirm the recommendation of thoracoscopic approach as a routine surgical procedure for operable SCLC, and until then, open surgery should still be considered.
基金:
National Key R&D Program of China ( 2017YFC0113500 ), Major Science and Technology Projects of Zhejiang Province ( 2020C03058 ), Diagnosis and Treat- ment Technology Research Center of Pulmonary Neoplasm in Zhejiang Province ( JBZX-202007 ), and Key Disciplines of Tradi- tional Chinese Medicine in Zhejiang Province ( 2017-XK-A33 ).
第一作者机构:[1]Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China[*1]Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qing-chun Road, Hangzhou, Zhejiang 310003, China
推荐引用方式(GB/T 7714):
Xu Jinming,He Tianyu,Wu Yihe,et al.VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis.[J].CLINICAL LUNG CANCER.2022,23(2):170-176.doi:10.1016/j.cllc.2021.06.007.
APA:
Xu Jinming,He Tianyu,Wu Yihe,Cao Jinlin,Han Xingpeng...&Hu Jian.(2022).VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis..CLINICAL LUNG CANCER,23,(2)
MLA:
Xu Jinming,et al."VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis.".CLINICAL LUNG CANCER 23..2(2022):170-176